PURPOSE: To review the proportion of diabetic patients reaching recommended therapeutic goals, as reported in intervention trials and observational studies, and to analyse the factors associated with success or failure in achieving these targets. METHODS: A systematic review and meta-analysis through a Medline and Embase search for "diabetes" and "HbA1c" has been performed between 1 January 1995 and 1 March 2012 on randomised clinical trials and observational studies on type 1 (T1DM) or type 2 diabetes (T2DM) enrolling at least 200 patient*year. RESULTS: Out of 169 patient groups in RCTs with results available for analysis, the overall proportion of patients reaching HbA1c ≤ 7 % was 36.6 (34.1-39.1) %. Of these, 8 groups included T1DM subjects [proportion at target (PAT) 27.2 (22.7-32.3) %] and 161 T2DM patients [PAT 37.1 (34.5-39.7) %]. In patients with T2DM on oral agents, at multivariate analysis, higher success rate was associated with higher age and body mass index (BMI), lower duration of diabetes, lower proportion of Caucasians and more recent publication year. Among the insulin treated, only duration of diabetes retained a significant association with success rate. Among 41 groups from cross-sectional studies, 6 and 22 were composed of patients with T1DM and T2DM, respectively, and the remaining 13 included both types. Patients at target for HbA1c were 19.8 (12.4-30.1), 36.1 (31.5-41.0), and 39.0 (32.9-45.3) %, respectively. Higher age, lower BMI, shorter duration of diabetes and a higher proportion of males and Caucasians were associated with a higher success rate. CONCLUSIONS: Available data show that a wide distance remains between recommended targets and actual achievements in routine clinical practice.
PURPOSE: To review the proportion of diabeticpatients reaching recommended therapeutic goals, as reported in intervention trials and observational studies, and to analyse the factors associated with success or failure in achieving these targets. METHODS: A systematic review and meta-analysis through a Medline and Embase search for "diabetes" and "HbA1c" has been performed between 1 January 1995 and 1 March 2012 on randomised clinical trials and observational studies on type 1 (T1DM) or type 2 diabetes (T2DM) enrolling at least 200 patient*year. RESULTS: Out of 169 patient groups in RCTs with results available for analysis, the overall proportion of patients reaching HbA1c ≤ 7 % was 36.6 (34.1-39.1) %. Of these, 8 groups included T1DM subjects [proportion at target (PAT) 27.2 (22.7-32.3) %] and 161 T2DM patients [PAT 37.1 (34.5-39.7) %]. In patients with T2DM on oral agents, at multivariate analysis, higher success rate was associated with higher age and body mass index (BMI), lower duration of diabetes, lower proportion of Caucasians and more recent publication year. Among the insulin treated, only duration of diabetes retained a significant association with success rate. Among 41 groups from cross-sectional studies, 6 and 22 were composed of patients with T1DM and T2DM, respectively, and the remaining 13 included both types. Patients at target for HbA1c were 19.8 (12.4-30.1), 36.1 (31.5-41.0), and 39.0 (32.9-45.3) %, respectively. Higher age, lower BMI, shorter duration of diabetes and a higher proportion of males and Caucasians were associated with a higher success rate. CONCLUSIONS: Available data show that a wide distance remains between recommended targets and actual achievements in routine clinical practice.
Authors: Katarina Eeg-Olofsson; Jan Cederholm; Peter M Nilsson; Soffia Gudbjörnsdóttir; Björn Eliasson Journal: Diabetes Care Date: 2007-03 Impact factor: 19.112
Authors: N Wah Cheung; Jennifer J Conn; Michael C d'Emden; Jenny E Gunton; Alicia J Jenkins; Glynis P Ross; Ashim K Sinha; Sofianos Andrikopoulos; Stephen Colagiuri; Stephen M Twigg Journal: Med J Aust Date: 2009-09-21 Impact factor: 7.738
Authors: Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews Journal: Diabetes Care Date: 2012-04-19 Impact factor: 19.112
Authors: Stephen M Twigg; Javier Escalada; Peter Stella; Ana Merino-Trigo; Fernando J Lavalle-Gonzalez; Bertrand Cariou; Luigi F Meneghini Journal: Diabetes Ther Date: 2018-09-10 Impact factor: 2.945
Authors: Sara Deola; Bella S Guerrouahen; Heba Sidahmed; Anjud Al-Mohannadi; Muhammad Elnaggar; Ramaz Elsadig; Essam M Abdelalim; Goran Petrovski; Massimo Gadina; Adrian Thrasher; Winfried S Wels; Stephen P Hunger; Ena Wang; Francesco M Marincola; Cristina Maccalli; Chiara Cugno Journal: J Transl Med Date: 2018-10-10 Impact factor: 5.531
Authors: Pablo Aschner; Juan J Gagliardino; Hasan Ilkova; Fernando Lavalle; Ambady Ramachandran; Jean Claude Mbanya; Marina Shestakova; Jean-Marc Chantelot; Juliana C N Chan Journal: Diabetologia Date: 2020-01-04 Impact factor: 10.122